Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Johnson & Johnson
Pharma
ASH: GSK details Blenrep's survival win against J&J's Darzalex
Blenrep cut the risk of death by 42% compared with Darzalex in the meds' respective combinations with Vd in second- or later-line multiple myeloma.
Angus Liu
Dec 9, 2024 1:30pm
UK talc claimants set to file suit in class action vs. J&J
Nov 22, 2024 11:18am
China cuts, CSL site closure and Kyowa deal—Fierce Pharma Asia
Nov 22, 2024 3:00am
With 'headwinds' in China, J&J, Merck execute layoffs
Nov 20, 2024 11:31am
New IL-23 UC drugs 'rapidly gained significant momentum': report
Nov 18, 2024 8:55am
EU regulators endorse meds from BMS, J&J, Eisai and more
Nov 15, 2024 10:05am
